missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ SV2A Monoclonal Antibody (K70011_6B6), Invitrogen™
Description
Sequence of this protein is as follows: FIRGAKDIAK EVKKHAAKKV VKGLDRVQDE YSRRSYSRFE EEDDDDDFPA PSDGYYRGEG TQDEEEGGAS SDATEGHDED DEIYEGEYQG IPRAESGGKG ERMADGAPLA GVRGGLSDGE GPPGGRGEAQ RRKEREELAQ QYEAILRECG
This protein plays a role in the control of regulated secretion in neural and endocrine cells, enhancing selectively low-frequency neurotransmission. Positively regulates vesicle fusion by maintaining the readily releasable pool of secretory vesicles.It is identified as the brain binding-site for the antiepileptic drug levetiracetam/lev.
Specifications
Specifications
| Antigen | SV2A |
| Applications | Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot |
| Classification | Monoclonal |
| Clone | K70011_6B6 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol, 0.5% BSA and 0.09% sodium azide |
| Gene | SV2A |
| Gene Accession No. | Q02563, Q7L0J3 |
| Gene Alias | AI746429; calcium regulator SV2A; Kiaa0736; mKIAA0736; PSEC0174; SV2; SV2A; synaptic vesicle glycoprotein 2 a; synaptic vesicle glycoprotein 2a; Synaptic vesicle protein 2; synaptic vesicle protein 2A; synaptic vesicle transmembrane transporter (SV2) RNA |
| Show More |